Proceedings: Influence of oxymetazoline and phentolamine on noradrenaline (NA) release caused by electrical stimulation, potassium, tyramine and dimethylphenylpiperazine (DMPP).
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D004558:Electric Stimulation; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology*; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D014663:Nasal Decongestants / Q000494:pharmacology*; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D010109:Oxymetazoline / Q000494:pharmacology; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology*; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology*
D005731:Ganglionic Stimulants; D007093:Imidazoles; D014663:Nasal Decongestants; D010879:Piperazines; D014316:Tritium; D004246:Dimethylphenylpiperazinium Iodide; D010109:Oxymetazoline; D011188:Potassium; D009638:Norepinephrine; D014439:Tyramine; D010646:Phentolamine